A variety of immune-based therapies are under consideration to improve immunological functions in human immunodeficiency virus (HIV)-infected patients. Whereas several therapeutic approaches have failed to improve immunological parameters or provide a clear clinical benefit, the use of interleukin-2
No takes yet. Share an insight, caveat, or question.
Paolo De Paoli (2001) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: